180 related articles for article (PubMed ID: 5066341)
21. Immune responses of human lymphocytes in vitro.
Haynes BF; Katz P; Fauci AS
Prog Clin Immunol; 1980; 4():23-62. PubMed ID: 6992219
[No Abstract] [Full Text] [Related]
22. Protection of mice against syngeneic C1300 neuroblastoma challenge by immunization with membranes of C1300 neuroblastoma cells.
Lauro G; Businaro R; Butler RH; Revoltella R
J Natl Cancer Inst; 1980 May; 64(5):1169-72. PubMed ID: 6929017
[TBL] [Abstract][Full Text] [Related]
23. [Destabilization of the plasma membrane as a mechanism of protecting neoplastic cells from the action of immunity].
Volkov EI; Chernavskii DS
Usp Sovrem Biol; 1981; 91(3):419-32. PubMed ID: 7027660
[No Abstract] [Full Text] [Related]
24. Cellular immunity and blocking antibodies to tumors.
Hellström I; Hellström KE
J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
[No Abstract] [Full Text] [Related]
25. The immune system and cancer.
Gallucci B
Oncol Nurs Forum; 1987; 14(6 Suppl):3-12. PubMed ID: 3320984
[No Abstract] [Full Text] [Related]
26. [Cellular immunity against tumor cells].
Hashimoto Y
Saishin Igaku; 1970 May; 25(5):1018-22. PubMed ID: 4912175
[No Abstract] [Full Text] [Related]
27. Dendritic cell vaccines for cancer therapy.
Sprinzl GM; Kacani L; Schrott-Fischer A; Romani N; Thumfart WF
Cancer Treat Rev; 2001 Aug; 27(4):247-55. PubMed ID: 11545544
[TBL] [Abstract][Full Text] [Related]
28. [Immune-surveillance and tumors: current concepts].
Bariffi F
Arch Monaldi; 1976; 31(4):268-78. PubMed ID: 1030625
[No Abstract] [Full Text] [Related]
29. Immunodeficiency and immunobiology.
Wedgwood RJ
Pediatrics; 1971 May; 47(5):801-6. PubMed ID: 5103317
[No Abstract] [Full Text] [Related]
30. [Cancer and immunity].
Cerottini JC; Mach JP
Rev Med Suisse Romande; 1974 Sep; 94(9):675-84. PubMed ID: 4438877
[No Abstract] [Full Text] [Related]
31. Introduction: interaction of humoral and cellular mechanisms in tumor immunity.
Hellström KE
Natl Cancer Inst Monogr; 1972 Dec; 35():221-2. PubMed ID: 4667436
[No Abstract] [Full Text] [Related]
32. Blood group T and Tn antigens are universal, clonal, epithelial cell-adhesive, autoimmunogenic carcinoma markers.
Springer GF
Prog Clin Biol Res; 1983; 133():157-66. PubMed ID: 6622492
[No Abstract] [Full Text] [Related]
33. Studies of tumor-specific and herpesvirus nonvirion antigens.
Hollinshead A; Tarro G; Foster WA; Seigel LJ; Jaffurs W
Cancer Res; 1974 May; 34(5):1122-5. PubMed ID: 4842911
[No Abstract] [Full Text] [Related]
34. [Cellular immunity to tumor antigens].
Hellström KE; Hellström I
Lakartidningen; 1974 Feb; 71(6):473-8. PubMed ID: 4837237
[No Abstract] [Full Text] [Related]
35. Tumor specific antigen appearance on normal cells during intermediate steps of viral carcinogenesis.
Celada F
Boll Ist Sieroter Milan; 1971; 50(3):176-84. PubMed ID: 5169543
[No Abstract] [Full Text] [Related]
36. [Lymphocytes and the immune response. Membrane receptors of lymphocytes].
Rev Prat; 1975 Dec; 25(57):4604-10. PubMed ID: 1215790
[No Abstract] [Full Text] [Related]
37. Lipopolysaccharide (LPS) regulation of the immune response: LPS influence on oral tolerance induction.
Michalek SM; Kiyono H; Wannemuehler MJ; Mosteller LM; McGhee JR
J Immunol; 1982 May; 128(5):1992-8. PubMed ID: 6460815
[No Abstract] [Full Text] [Related]
38. Regulation of immune response in cancer by plasma: the postulated role of transcortin.
Amaral L; Werthamer S
Ann Clin Lab Sci; 1974; 4(6):435-40. PubMed ID: 4429341
[No Abstract] [Full Text] [Related]
39. Interference of immunologic surveillance by immunoregulatory alpha globulin--a hypothesis.
Ablin RJ
Neoplasma; 1973; 20(2):159-62. PubMed ID: 4122507
[No Abstract] [Full Text] [Related]
40. The future of tumor immunology.
Cinader B
Med Clin North Am; 1972 May; 56(3):801-36. PubMed ID: 4113771
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
